MONDAY, OCTOBER 23, 2017

North Dakota reports first West Nile virus case of 2015

The North Dakota Department of Health (NDDoH) recently confirmed the state’s first West Nile virus human case for 2015. Read More »

New study shows U.S. hospitalizations for adults with pneumonia

The Centers for Disease Control and Prevention (CDC) recently published a study detailing the cause of pneumonia hospitalizations for adults in the U.S. Read More »

HPV vaccine required in only two U.S. states

A recent evaluation of state vaccination requirements for teenagers has discovered that only two states in the U.S. require the human papillomavirus (HPV) vaccine. Read More »

U.N. encourages malaria elimination

U.N. Secretary-General Ban Ki-moon recently made a statement emphasizing the incredible opportunity that is at hand: the opportunity to eliminate malaria from the world’s health concerns. Read More »

Oxford Vaccines Group begins Phase 2 study of Ebola vaccines

Bavarian Nordic, the Oxford Vaccines Group recently started its Phase 2 clinical study involving a combination of Bavarian Nordic’s MVA-BN Filo vaccine and Janssen’s Ad26.ZEBOV vaccine. Read More »

Feds seek more assistance in design, testing of vaccines against HIV in humans

The main goal of a current federal Funding Opportunity Announcement is to examine vaccines that have been shown to prevent SIV and SHIV infection in nonhuman primates and determine how they work, says the NIAID branch chief overseeing the FOA. Read More »

Health officials discuss elimination of polio in Africa

Health officials recently met to discuss the best ways to maintain the eradication of polio in Ethiopia and Africa, a meeting held in light of an outbreak of wild polio virus in the Horn of Africa. Read More »

Unilever collaborates with Amref Health Africa to fight cholera outbreak

Unilever East Africa and Amref Health Africa recently partnered to improve government efforts in controlling and stopping the spread of the cholera outbreak. Read More »

Immunologists find antibody-producing cells in bone marrow

A team of immunologists from Emory University recently identified a specific series of long-lived antibody-producing cells, essentially an archive of immunity, based inside bone marrow, the university announced.. Read More »

WHO gives prequalification status to Coartem malaria treatment

The World Health Organization (WHO) granted prequalification status Thursday to Coartem 80/480 mg, a malaria treatment created by Novartis, giving better access to patients. Coartem is the first fixed-dose, high strength artemisinin-based combination therapy (ACT) antimalarial treatment and also the first child-friendly ACT Read More »

Innovative tools to fight parasite cryptosporidium

A team of scientists from the University of Georgia recently created innovative tools to understand and genetically manipulate a microscopic parasite known as cryptosporidium, which causes a diarrheal disease called cryptosporidiosis. Read More »

HHS partnership furthers development of potential Ebola drug

The U.S. Department of Health and Human Services (HHS) said Wednesday its Office of the Assistant Secretary for Preparedness and Response (ASPR) recently partnered with the Center for Innovation in Advanced Development and Manufacturing (CIADM) to further develop and create a drug to treat the Ebola virus. The experimental drug is related to Mapp Biopharmaceuticals’ ZMapp, which was used in tobacco plants. Read More »

Research shows HIV spreads by manipulating immune system’s own mechanisms

A team of Canadian researchers at IRCM in Montreal, recently discovered that HIV evades the body’s immune system by using the immune system’s own mechanisms to defeat itself and allow the virus to spread. Read More »

Results from extensively drug-resistant TB treatment study released

Otsuka recently published the results of its Delamanid, or Deltyba, which is designed to treat extensively drug-resistant tuberculosis (XDR-TB), in the New England Journal of Medicine. Read More »

Action plan to end severe poverty by 2030 approved at Gavi conference

Gavi, the Vaccine Alliance, recently held a global conference about financing development platforms to achieve Sustainable Development Goals (SDGs). Government leaders and representatives from several nations recently attended the Financing for Development conference, where they approved the Addis Ababa Action Agenda. Read More »

Scientific Technologies begins Immunization Ambassador program

Scientific Technologies Corp. (STC) recently announced that it has launched its new Immunization Ambassador Program that is designed to make fun, collaborative efforts to encourage people to receive immunizations. Read More »

Global data released about immunization coverage

The World Health Organization and UNICEF recently released a joint publication that provides updated data about immunization coverage. According to the data, 123 countries vaccinated children with all three doses of the DTP3 vaccine in 2013. Read More »

R&D key to developing HIV prevention options

Positive results from several clinical trials have allowed new HIV prevention options, such as voluntary medical male circumcision and pre-exposure prophylaxis, to advance. Read More »

New Visterra antibody broadly neutralizes dengue virus in studies

Visterra Inc., a clinical-stage biotechnology company, recently announced that its novel antibody known as VIS513 has shown positive results in its preclinical studies, where the antibody broadly neutralized all four dengue virus serotypes. Read More »

Argos to present on HIV treatment at conference

Argos Therapeutics Inc., a biopharmaceutical company, recently announced that company representatives will give a presentation at the eighth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Read More »